Abstract

Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
Paolo Antonio Grossi ... Maria Buti
Journal of Hepatology | VOL. 74
Paolo Antonio Grossi, et. al.Paolo Antonio Grossi ... Maria Buti
06 Feb 2021
Safety of influenza vaccines in pregnant women
Flor M Munoz
American Journal of Obstetrics and Gynecology | VOL. 207
Flor M MunozFlor M Munoz
09 Jul 2012
Immune Response to Influenza Vaccine in Pediatric Patients With Inflammatory Bowel Disease
Petar Mamula ... Robert N Baldassano
Clinical Gastroenterology and Hepatology | VOL. 5
Petar Mamula, et. al.Petar Mamula ... Robert N Baldassano
04 Jun 2007
Nothing to Sneeze At: Efficacy and Cost-Effectiveness of the Influenza Vaccine in Patients Receiving Long-term Dialysis
Kevin C Abbott ... Christina M Yuan
American Journal of Kidney Diseases | VOL. 57
Kevin C Abbott, et. al.Kevin C Abbott ... Christina M Yuan
13 Apr 2011
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers